ArticleExploration of targeted anti-tumor therapy2021

Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors.

Ibrahim H Kankia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.